Similar articles

• Immunosuppressive therapy and tolerance of organ allografts.

  Starzl TE. Starzl TE. N Engl J Med. 2008 Jan 24;358(4):407-11. doi: 10.1056/NEJMe0707578. N Engl J Med. 2008. PMID: 18216363 Free PMC article. No abstract available.
• Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments.

  Leonard DA, McGrouther DA, Kurtz JM, Cetrulo CL Jr. Leonard DA, et al. Clin Dev Immunol. 2012;2012:863264. doi: 10.1155/2012/863264. Epub 2012 Dec 24. Clin Dev Immunol. 2012. PMID: 23320020 Free PMC article. Review.
• The changing immunology of organ transplantation.

  Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. Starzl TE, et al. Hosp Pract (1995). 1995 Oct 15;30(10):31-4, 37-42. doi: 10.1080/21548331.1995.11443268. Hosp Pract (1995). 1995. PMID: 7593387 Free PMC article. Review.
• Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.

  Huang WC, Lin JY, Wallace CG, Wei FC, Liao SK. Huang WC, et al. Clin Dev Immunol. 2012;2012:107901. doi: 10.1155/2012/107901. Epub 2012 Oct 22. Clin Dev Immunol. 2012. PMID: 23118778 Free PMC article. Review.
• Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.

  Lellouch AG, Ng ZY, Rosales IA, Schol IM, Leonard DA, Gama AR, Colvin RB, Lantieri LA, Randolph MA, Cetrulo CL Jr. Lellouch AG, et al. Plast Reconstr Surg. 2020 Apr;145(4):757e-768e. doi: 10.1097/PRS.0000000000006676. Plast Reconstr Surg. 2020. PMID: 32221215